Physician profile
John K Olson
NPI 1447254081
$657.81
in general payments reported to CMS, 2019-2025
16 companies · $3.29 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.20 · 2020: $26.39 · 2021: $236 · 2022: $161 · 2023: $153 · 2025: $3.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.70 | 2019-2023 | |
| Daiichi Sankyo INC. | $109.65 | 2022-2023 | Injectafer |
| Pfizer INC. | $46.11 | 2020-2023 | |
| Ethicon US, LLC | $30.28 | 2022 | |
| Therapeuticsmd, INC. | $30.05 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.58 | 2019-2022 | |
| Davol INC. | $25.00 | 2022 | |
| Exact Sciences Corporation | $17.82 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $16.45 | 2022 | |
| Medtronic, INC. | $14.83 | 2021 | |
| Covidien LP | $14.16 | 2019 | |
| Minerva Surgical, INC | $13.81 | 2023 | |
| Kci USA, INC. | $13.59 | 2019 | |
| Exeltis, USA INC. | $13.55 | 2023 | Slynd |
| Novo Nordisk INC | $12.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.